New test identifies CAD-affected children who may benefit from uridine

New test identifies CAD-affected children who may benefit from uridine

New test identifies CAD-affected children who may benefit from uridine

Scientists at Sanford Burnham Prebys Medical Discovery Institute and the Centro de Biología Molecular Severo Ochoa in Spain have created a test that determines which children with CAD deficiency-; a rare metabolic disease-; are likely to benefit from receiving uridine, a nutritional supplement that has dramatically improved the lives of other children with the condition.